TY  - JOUR
AU  - Hua, Stéphane
AU  - Vigano, Selena
AU  - Tse, Samantha
AU  - Zhengyu, Ouyang
AU  - Harrington, Sean
AU  - Negron, Jordi
AU  - Garcia-Broncano, Pilar
AU  - Marchetti, Giulia
AU  - Genebat, Miguel
AU  - Leal, Manuel
AU  - Resino, Salvador
AU  - Ruiz-Mateos, Ezequiel
AU  - Lichterfeld, Mathias
AU  - Yu, Xu G
PY  - 2018
DO  - 10.1093/cid/cix1111
UR  - http://hdl.handle.net/10668/11943
T2  - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
AB  - Interferon alpha (IFN-α) can potently reduce human immunodeficiency virus type 1 (HIV-1) replication in tissue culture and animal models, but may also modulate residual viral reservoirs that persist despite suppressive antiretroviral combination...
LA  - en
KW  - Adult
KW  - Aged
KW  - Antiretroviral Therapy, Highly Active
KW  - Cohort Studies
KW  - Coinfection
KW  - DNA, Viral
KW  - Disease Reservoirs
KW  - Female
KW  - HIV Infections
KW  - HIV-1
KW  - Hepacivirus
KW  - Hepatitis C
KW  - Humans
KW  - Interferon-alpha
KW  - Killer Cells, Natural
KW  - Lymphocyte Activation
KW  - Male
KW  - Middle Aged
KW  - Polyethylene Glycols
KW  - Recombinant Proteins
KW  - Ribavirin
KW  - Spain
KW  - Viral Load
KW  - gag Gene Products, Human Immunodeficiency Virus
TI  - Pegylated Interferon-α-Induced Natural Killer Cell Activation Is Associated With Human Immunodeficiency Virus-1 DNA Decline in Antiretroviral Therapy-Treated HIV-1/Hepatitis C Virus-Coinfected Patients.
TY  - research article
VL  - 66
ER  -